Overview

CRITIC Study is a multi-country initiative being implemented in Bhutan, India, Indonesia, Nepal, and Sri Lanka. This collaborative effort is being led by the Indian Council of Medical Research and The Union South-East Asia Office (USEA) and is funded by the Bill and Melinda Gates Foundation. The goal of the project tis to develop a comprehensive, patient-centric intervention strategy to improve retention in TB infection cascade of care for high TB risk groups in Nepal.

In collaboration with the National TB Control Centre the CRITIC study will research better ways to treat TB infection in adults who have a family member with TB in Nepal. We are using a treatment called 3HP, which needs to be taken once a week for three months, and is recommended by the World Health Organisation. Treating people with 3HP will stop them getting sick in the future and stop the TB disease spreading in communities.

PROJECT DURATION: March 2024 – March 2027